Now showing items 1-5 of 5
Geographic differences in baseline prostate inflammation and relationship with subsequent prostate cancer risk: results from the multinational REDUCE trial
(American Association for Cancer Research, 2018-04-18)
Background: Prostate cancer (PC) incidence rates vary 25-fold worldwide. Differences in PSA screening are largely, but not entirely, responsible. We examined geographic differences in prevalence of histologic prostate ...
Maternal protein malnutrition: Effects on prostate development and adult disease
(Cambridge University Press (CUP), 2018-03-27)
Well-controlled intrauterine development is an essential condition for many aspects of normal adult physiology and health. This process is disrupted by poor maternal nutrition status during pregnancy. Indeed, physiological ...
The Association of Previous Prostate Biopsy-Related Complications and the Type of Complication with Patient Compliance with Re-Biopsy Scheme
Introduction: Prostate biopsy complications have important consequences that may affect patient compliance with re-biopsy schemes; however, this has not been studied in earnest. Thus, we evaluated whether previous prostate ...
Nocturia and associated mortality: observational data from the REDUCE trial
(Springer Nature [academic journals on nature.com], 2018-09-13)
Importance: Nocturia (voids arising from sleep) is a ubiquitous phenomenon reflecting many diverse conditions, but whether it has significance in its own right remains uncertain. Objective: To determine whether nocturia ...
Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis
(Springer Nature, 2018-10-02)
BACKGROUND: We sought to evaluate prostate cancer (PCa) characteristics and outcomes of Hispanics living in the United States by country of origin in the Surveillance, Epidemiology and End Results (SEER) program. METHODS: ...